DOI: 10.3390/antibiotics15111063 ISSN: 2079-6382

Intestinal Colonization by Carbapenem-Resistant Gram-Negative Bacteria Harboring Carbapenemase and/or AmpC β-Lactamase Genes in Hospitalized Dogs and Cats in Brazil

Ricardo Antonio Pilegi Sfaciotte, Leandro Parussolo, Fernanda Danielle Melo, Naiara Dognani Israel, Luis Henrique Pompelli, Fabiano Zanini Salbego, Sandra Maria Ferraz

Background/Objectives: Hospitalized companion animals may act as reservoirs of multidrug-resistant (MDR) Gram-negative bacteria and contribute to the dissemination of clinically important antimicrobial resistance genes. This study investigated gastrointestinal colonization by carbapenem-resistant Gram-negative bacteria harboring carbapenemase and/or AmpC β-lactamase genes in dogs and cats admitted to a Brazilian veterinary teaching hospital. Methods: Rectal swabs were collected from 106 animals at admission and discharge. Isolates were identified by biochemical methods and MALDI-TOF, screened by multiplex PCR for carbapenemase and AmpC β-lactamase genes, and characterized by antimicrobial susceptibility testing. Results: Fourteen (13.2%) animals were colonized, including animals colonized at admission, those in which colonization was detected only at discharge, and those remaining colonized throughout hospitalization, yielding 18 Gram-negative isolates from five bacterial species. blaNDM predominated (61.1%), followed by blaKPC, blaOXA-48-like, and blaSPM (16.7% each). PCR-based detection indicated the co-occurrence of carbapenemase and AmpC β-lactamase gene families in 66.7% of isolates, including uncommon combinations such as blaKPC + blaSPM and blaOXA-48-like + blaPER + blaEBC in Pseudomonas aeruginosa, without sequence-level confirmation. All isolates were MDR. Conclusions: Hospitalized companion animals may serve as reservoirs of clinically important MDR Gram-negative bacteria carrying carbapenemase and β-lactamase AmpC genes. These findings highlight the role of veterinary hospitals in the epidemiology of antimicrobial resistance and reinforce the need for molecular surveillance, antimicrobial stewardship, and infection prevention within a One Health framework.

More from our Archive